Gilead Sciences, Inc. (GILD)
151.68
-0.82
(-0.54%)
USD |
NASDAQ |
Feb 09, 16:00
150.33
-1.35
(-0.89%)
After-Hours: 07:44
Gilead Sciences Total Assets (Quarterly) : 58.53B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 90.59B |
| Johnson & Johnson | -- |
| Eli Lilly & Co. | -- |
| Merck & Co., Inc. | -- |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.08B |
| Shareholders Equity (Quarterly) | 21.54B |
| Debt to Equity Ratio | 1.158 |
| Current Ratio | 1.453 |
| Net Debt Paydown Yield | -0.23% |